Results 11 to 20 of about 204,079 (163)

COVID-19 Vaccination and The Eye [PDF]

American Journal of Ophthalmology, 2022
To summarize the current evidence on COVID-19 vaccine-associated ocular adverse events.Narrative literature review.The literature search was conducted in August 2021 using 4 electronic databases: MEDLINE, EMBASE, PubMed, and the Cochrane Database of Systematic Reviews.
Michael T.M. Wang, Rachael L. Niederer, Charles N.J. McGhee, Helen V. Danesh-Meyer   +3 more
openaire   +2 more sources

The Time for COVID-19 Vaccination

Journal of Virology, 2021
The composition and dynamics of viral mutant spectra in infected individuals advise that to avoid selection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escape mutants, vaccination campaigns for coronavirus disease 2019 (COVID-19) should be launched when disease incidence is low.
Domingo, Esteban, Perales, Celia
openaire   +4 more sources

COVID‐19: vaccine’s progress [PDF]

Microbial Biotechnology, 2021
Summary Under the pressure of the COVID‐19 pandemic, vaccines were developed and rolled out into mass vaccination campaigns at incredible speed. What normally takes a decade was worked out within a year. Vaccines were produced along many different platforms ranging from inactivated whole virus vaccines over adenovirus‐vectored ...
openaire   +4 more sources

COVID-19 Vaccine Development to Vaccination

Journal of Nepal Health Research Council, 2021
In the race for a safe and effective vaccine against Coronavirus disease-19 manufacturer plays a critical role throughout the development, clinical trial, manufacturing, supply, and vaccination phases. For the efficacy of Coronavirus disease-19 vaccine, proper transport, storage, vaccine carrier, adjuvant, dosage form and route of vaccine ...
Ashok Pandey, Pradeep Belbase, Ayuska Parajuli   +2 more
openaire   +2 more sources

COVID-19 vaccines for children [PDF]

Science, 2021
Earlier this month, the US Centers for Disease Control and Prevention (CDC) recommended Pfizer’s COVID-19 messenger RNA (mRNA) vaccine for children between 5 and 11 years of age—that’s 28 million children. Yet surveys show that 42 to 66% of parents of these children are reluctant or opposed to seeking this protection.
Jeffrey S, Gerber, Paul A, Offit
openaire   +2 more sources

Facilitators and barriers to COVID-19 vaccination among incarcerated people and staff in three large, state prisons: a cross-sectional study

Health & Justice, 2023
Background The COVID-19 pandemic has disproportionately impacted individuals in carceral facilities – both incarcerated people and staff. Vaccination is an important tool in reducing the risk of COVID-19 infection, hospitalization, and death.
Ingie Osman, Antonio Williams, Katie Pierson, Eric Ryu, Rebecca J. Shlafer   +4 more
doaj   +1 more source

COVID‐19 vaccine‐associated organizing pneumonia

Respirology Case Reports, 2022
We report the first case of organizing pneumonia (OP) associated with a new coronavirus disease (COVID‐19) vaccination. A 78‐year‐old woman developed cough and dyspnoea 10 days after receiving BNT162b2.
Tomohiro Yoshikawa, Katsuyoshi Tomomatsu, Eriko Okazaki, Tomoe Takeuchi, Yukihiro Horio, Yusuke Kondo, Tsuyoshi Oguma, Koichiro Asano   +7 more
doaj   +1 more source

Covid-19 Vaccine Acceptance and Determinants– An Online Cross-Sectional Survey in Kerala, India

National Journal of Community Medicine, 2021
Background: Covid-19 vaccination threshold is key to pandemic control. This study aimed to assess the Covid-19 vaccine acceptance and determinants at Kerala, India. Methods: A cross-sectional web- based study was conducted in Kerala, India from April-
Pratibha Dabas, Krishna JS Raj , Jossy John, Manisha Wadhwa, Lulu Manoly, Raseena PA   +5 more
doaj   +1 more source

Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination

Circulation Research, 2022
The risk of stroke and cerebrovascular disease complicating infection with SARS-CoV-2 has been extensively reported since the onset of the pandemic. The striking efforts of many scientists in cooperation with regulators and governments worldwide have rapidly brought the development of a large landscape of vaccines against SARS-CoV-2.
Manuela De Michele, Joshua Kahan, Irene Berto, Oscar G. Schiavo, Marta Iacobucci, Danilo Toni, Alexander E. Merkler   +6 more
openaire   +3 more sources

Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States

Frontiers in Immunology, 2021
The arrival of the COVID-19 vaccine has been accompanied by increased discussion of vaccine hesitancy. However, it is unclear if there are shared patterns between general vaccine hesitancy and COVID-19 vaccine rejection, or if these are two different ...
Shu-Fang Shih, Abram L. Wagner, Nina B. Masters, Lisa A. Prosser, Lisa A. Prosser, Yihan Lu, Brian J. Zikmund-Fisher, Brian J. Zikmund-Fisher   +7 more
doaj   +1 more source